ReviewCancer medicine2021

PD-1/PD-L1 inhibitors-based treatment for advanced renal cell carcinoma: Mechanisms affecting efficacy and combination therapies.

Lei Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.